Brand family
Steglatro
Ertugliflozin pidolate and Ertugliflozin · Merck Sharp & Dohme
European UnionUnited States
- Presentations
- 2
- Markets
- 2
Steglatro is a brand of Ertugliflozin pidolate and Ertugliflozin marketed by Merck Sharp & Dohme, with 2 presentations listed and registered in European Union, United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Ertugliflozin pidolate, Ertugliflozin
- Brand owner
- Merck Sharp & Dohme
- Registered in
- European Union, United States
- Strengths and forms
- 15 mg tablet, 5 mg tablet
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Steglatro 15 mg tabletOral | Merck Sharp & Dohme | US FDA | Available on request |
| Steglatro 5 mg tabletOral | Merck Sharp & Dohme | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Steglatro
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.